Alopecia secondary to anti-tumor necrosis factor-alpha therapy
An. bras. dermatol
;
90(2): 232-235, Mar-Apr/2015. graf
Artículo
en Inglés
| LILACS
| ID: lil-741064
ABSTRACT
Biologic drugs represent a substantial progress in the treatment of chronic inflammatory immunologic diseases. However, its crescent use has revealed seldom reported or unknown adverse reactions, mainly associated with anti-tumor necrosis factor (anti-TNF). Psoriasiform cutaneous reactions and few cases of alopecia can occur in some patients while taking these drugs. Two cases of alopecia were reported after anti-TNF therapy. Both also developed psoriasiform lesions on the body. This is the second report about a new entity described as 'anti-TNF therapy-related alopecia', which combines clinical and histopathological features of both alopecia areata and psoriatic alopecia. The recognition of these effects by specialists is essential for the proper management and guidance of these patients.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Psoriasis
/
Enfermedad de Crohn
/
Antiinflamatorios no Esteroideos
/
Factor de Necrosis Tumoral alfa
/
Alopecia
/
Anticuerpos Monoclonales
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Adolescente
/
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
An. bras. dermatol
Asunto de la revista:
Dermatologia
Año:
2015
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Faculdade de Medicina do ABC/BR
Similares
MEDLINE
...
LILACS
LIS